Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 305.59
+4.59 (1.52%)
At close: Sep 12, 2025
Cencora Market Cap
Cencora has a market cap or net worth of 43.28 billion as of September 15, 2025. Its market cap has increased by 25.12% in one year.
Market Cap
43.28B
Enterprise Value
49.29B
Revenue
231.13B
Ranking
n/a
PE Ratio
31.25
Stock Price
305.59
Market Cap Chart
Since April 4, 1995, Cencora's market cap has increased from 199.85M to 43.28B, an increase of 21,556.52%. That is a compound annual growth rate of 19.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 43.28B | 24.77% |
| Dec 31, 2024 | 34.69B | 8.10% |
| Dec 29, 2023 | 32.09B | 15.46% |
| Dec 30, 2022 | 27.79B | 36.06% |
| Dec 31, 2021 | 20.43B | 39.67% |
| Dec 31, 2020 | 14.62B | 10.64% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |